Decarbonization Plus Acquisition $200 million IPO
Davis Polk advised the underwriters in connection with the $200 million initial public offering of 20,000,000 units of Decarbonization Plus Acquisition Corporation. Each unit consists…
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Primo Water Holdings €450 million senior notes offering
Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering of €450 million aggregate principal amount of senior notes due…
Promigas and Gases del Pacífico $120 million notes offering
Davis Polk advised the initial purchasers in connection with the offering by Promigas S.A. E.S.P. and its subsidiary Gases del Pacífico S.A.C., as co-issuers, of $120 million aggregate…
Morgan Stanley $1 billion inaugural offering of social bonds
Davis Polk advised Morgan Stanley in connection with its SEC-registered global offering of $1 billion aggregate principal amount of fixed-to-floating-rate senior notes due 2025. During the…
Bansk Group acquisition of Woodstream and related financing
Davis Polk is advising Bansk Group in connection with its acquisition of Woodstream Corporation. Bansk Group is a private investment group focused on growth companies and has approximately …
Lightyear Capital & Ontario Teachers’ Pension acquisition of Allworth Financial
Davis Polk is advising Lightyear Capital and Ontario Teachers’ Pension Plan Board on their acquisition of wealth management firm Allworth Financial from private equity funds managed by…
Aligos Therapeutics $150 million IPO
Davis Polk advised the representatives of the several underwriters in connection with the $150 million initial public offering of 10,000,000 shares of common stock of Aligos…
Eargo $165.2 million IPO
Davis Polk advised the representatives of the several underwriters in connection with an initial public offering of 9,029,629 shares of common stock of Eargo, Inc. at $18.00 per share …
H.B. Fuller $300 million notes offering
Davis Polk advised the representatives of the several underwriters in connection with an SEC-registered debt issuance by H.B. Fuller Company of $300 million of its 4.250% notes due 2028…
Royalty Pharma $728 million secondary offering
Davis Polk advised Royalty Pharma plc and the selling shareholders on Royalty Pharma’s $728 million secondary offering of 17,343,037 of its Class A ordinary shares by certain selling…